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Diabetes is a risk factor for tuberculosis in the Inuit
population of Greenland
To the Editors:
Diabetes is a known risk factor for tuberculosis (TB), and studies
across populations and geographic regions suggest substantial
increased risks of developing TB ranging from 1.16 to 7.83 with
co-existing diabetes [1]. It is suggested that the risk is due to
latent TB infections being activated by the hyperglycemia
associated with diabetes. The evolving epidemiology of con-
current diabetes and TB in settings where both diseases are
frequent is therefore looked upon with special concern. The
prevalence of diabetes among the Greenland Inuit is high (10%)
and increasing [2]. Meanwhile, the TB incidence remains high
with an estimated 180 cases per 100,000 suggesting ongoing TB
transmission [3]. The aim of this study was to quantify the effect
of diabetes on TB development among the Greenland Inuit.
We conducted a retrospective cohort study. Study participants
comprised ethnic Inuit who participated in two previously
conducted cross-sectional studies where diabetes status were
assessed; Inuit Health in Transition Study (IHIT) [4] and the
Greenland Population Study (B99) [2]. All study participants in
IHIT and B99 were randomly selected from the Civil Registration
System (CRS) in order to represent the entire Greenlandic
population. The CRS provides all citizens of Greenland with a
unique identification number at birth, facilitating tracing of
persons through all public registries. The CRS identifier enabled
follow-up of study participants in the National TB register. The
study was approved by the Ethics Review of Greenland.
Participants not previously diagnosed with diabetes (98%)
underwent a standard oral glucose tolerance test (OGTT).
Participants were categorised with diabetes if previously
diagnosed with diabetes or if fasting and 2-h blood glucose
levels were o7 mmol?L-1 and o11.1 mmol?L-1, respectively.
Weight and height were measured and body mass index (BMI)
calculated. Age and sex of participants were determined from
CRS data. Place of residence, divided into town or settlement,
was likewise derived from the CRS registry.
TB is a mandatory notifiable disease in Greenland and all
incident cases diagnosed by a medical doctor are recorded in
the National TB register [5]. For the present study, all incident c
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TB cases recorded among the study participants were retrieved
from the National TB register; however, only TB cases record-
ed after diabetes assessment were included in the study.
Diabetes status, age, sex, place of residence and BMI retrieved
from B99 and IHIT were linked to the National TB register and
the death register by the CRS number. Participants were
followed from entry into either B99 or IHIT until TB diagnosis,
death/emigration or December 31 2010, whichever came first.
The incidence rate ratios (RRs) for developing TB according to
diabetes status were estimated by log-linear Poisson regres-
sion, using the logarithm of person years as offset. The RRs
were adjusted for BMI, age, sex and place of residence in a
multivariate regression analyses. To evaluate the robustness of
our results, we also estimated the crude estimate using exact
Poisson regression with mid-p confidence intervals (CIs). This
only led to a minor widening of the confidence interval. Level
of significance was set at 5%. All analyses were performed in
SAS version 9.2 (SAS Institute, Cary, NC, USA).
A total of 3,012 study participants were identified as Inuit and
registered in CRS, of these 276 were excluded from further
analysis for not meeting the inclusion criteria (prior TB (n5257)
and missing sample dates (n519)). 2,736 were included in the
analyses. Mean follow-up was 4.97 yrs. Approximately 44%
were males (49% in Greenland as a whole), and the median age
was 45 yrs (interquartile range: 37–56 yrs) (40 yrs in Greenland
(interquartile range: 30–50 yrs)). Median BMI was 25.6 kg?m-2
(interquartile range: 22.5–29.5 kg?m-2) and 74% lived in towns.
A total of 281 (10.3%) participants had diabetes and 11 (0.4%)
were registered with TB during follow-up. The unadjusted TB
incidence rate was 2.66 times higher in participants with diabetes
compared with participants without diabetes (table 1). Adjusting
for age, sex, BMI and place of residence, however, entailed a
significantly increased RR of 11.7 (p,0.01). High BMI and female
sex had a protective effect on the risk of developing TB.
The present study is, to our knowledge, the first study to explore
and quantify the effect of diabetes on the risk of developing TB
in an Inuit population. The present study found the TB
incidence rate to be 11.7 times higher among Inuit with diabetes
relative to Inuit without when adjusting for age, sex, place of
residence and BMI. The results of the present study are overall
in accordance with similar studies assessing the link between
diabetes and TB. However, the magnitude of the RR in this
study is higher than the risk identified in most studies. Thus, a
prospective study from Mexico found a seven-fold increase in
TB rates among persons with diabetes relative to persons
without diabetes [6]. The link between diabetes and TB was also
explored in indigenous populations; thus MORI et al. [7], found
diabetes to be more frequent in Oglala Sioux Indians diagnosed
with TB compared with Indians without TB (odds ratio 5.2).
Surprisingly, a study of TB risk factors recently conducted in
Greenland, could not identify diabetes as a risk factor for TB [8].
However, diabetes was self-reported in the study and therefore
subject to major under-reporting as an estimated 70% of people
with diabetes in Greenland are unaware of their diabetes [2].
Additionally, the study population comprised mixed Inuit/
Danish ethnicity. A study from Denmark found an odds ratio of
1.18 (95% CI 0.96–1.45) of active TB with a prior diagnosis of
diabetes [9]; the discrepancy to our study is most likely due to the
low risk of latent TB in Denmark compared with Greenland [10].
Adjusting for age, sex, BMI and place of residence entailed a
dramatic increase in the RR due to the strong association between
BMI and TB, and between sex and TB. The apparent strengthen-
ing of risk estimates after confounder adjustment has been found
in similar studies [1, 7]. The seemingly protective effect of a
higher BMI is in accordance with studies suggesting underweight
to be a substantial risk factor for active TB [8]. Nonetheless, it is
also plausible that persons with advanced TB symptoms (e.g.
extensive weight loss) are more likely to seek medical attention
and, therefore, more often registered with TB. However, a low
BMI may also be an expression of more advanced diabetes and
hence, longer duration of unknown diabetes. It is well known that
the TB incidence is lower among females, which is also in
accordance with the finding in this study [8]. Likewise,
participants living in towns had lower RR of developing TB than
participants living in settlements, consistent with one study,
where living in settlements was a risk factor for TB [8].
A major strength of the present study is the longitudinal
study design allowing the calculation of RR and thus assessing
the temporal order of the association of diabetes and TB.
Furthermore, as diabetes is unknown in an estimated 70% of
diabetes cases in Greenland [2], the assessment of diabetes from
OGTT is a substantial strength. Likewise, TB cases are diagnosed
by a medical professional and microbiologically confirmed
before registration in the National TB register.
Furthermore, as assessment of diabetes is made at point of
study entry in IHIT and B99, the duration of diabetes exposure,
is not taken into account. Hence, unknown diabetes may have
facilitated the occurrence of TB before a confirmed diabetes
diagnosis, underestimating the effect of diabetes on the risk of
TB development. Additionally, it is possible that unmeasured
confounders, not adjusted for in the present study may account
for some of the effect of diabetes on the risk of developing TB.
TABLE 1 Incidence rate ratio (RR) of tuberculosis with
co-existing diabetes
RR 95% CI
Crude
Diabetes 2.66 0.41–10.3
Non-diabetes 1
Adjusted#
Diabetes 11.7* 1.48–65.9
BMI kg?m-2 0.67* 0.51–0.84
Age yrs 0.93* 0.88–0.97
Sex
Males 1
Females 0.16* 0.02–0.63
Place of residence
Town 1
Settlement 1.82 0.47–6.11
BMI: body mass index. #: adjusted for age, sex, place of residence and BMI.
*: p,0.05.
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The contribution of diabetes is still widely overlooked in TB
prevention efforts [1]. In this sample of Greenland Inuit where
both HIV and undernutrition remain uncommon, the risk of
developing TB was markedly higher in persons with co-existing
diabetes than in persons without. The very high risk associated
with diabetes suggests potential reduction in the Greenland TB
incidence rates through incorporating diabetes control and
prevention in TB prevention schemes. However, the validity of
the results should be confirmed in a larger sample size, pre-
ferentially by applying longer follow-up time to the study cohort.
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Outcomes of a tuberculosis contact investigation
programme in Italy
To the Editors:
Mycobacterium tuberculosis transmission is affected by several
key factors, such as contagiousness of the index tuberculosis
(TB) case, immune status and susceptibility of the exposed TB
contact, duration and patterns of contact between the index TB
case and the exposed TB contact, and characteristics of the
environment within which such contact occurs [1–3]. Tracing
strategies that allow the early identification and appropriate
treatment of TB contacts with latent TB infection (LTBI) or
active TB should be a priority of TB control programmes with
adequate resources [3, 4].
In agreement with the guidelines laid out by the Italian Ministry
of Health, the Piedmont Region has activated and regularly
updated TB contact investigation procedures [5]. We used data
from the Piedmont Region TB contact investigation programme to
assess the role of selected risk factors for TB infection (TBI) among
TB contacts in the city of Turin, Italy. For each suspected or
confirmed pulmonary TB case, active contact investigation was
conducted among household members, close contacts and regular
contacts, defined according to the stone-in-the-pond method [6].
Passive investigation was used for occasional contacts [5].
The Piedmont TB notification systems were used to identify
pulmonary TB cases between January 2002 and December 2008.
TB cases were classified into three categories of contagious-
ness: 1) sputum smear-positive and culture-positive (acid-fast
bacillus positive (AFB+)); 2) sputum smear-negative but culture-
positive (CULT+); and 3) sputum smear-negative and culture-
negative or not examined, i.e. other than defined (OtD).
Interviews were conducted with each TB case to identify TB
contacts, defined as anyone having shared air with an active TB
case. All traced TB contacts were screened for active TB or LTBI
using the tuberculin skin test (TST). The TST was performed
using tuberculin purified protein derivative (5 IU) according to
the Mantoux method [3]. TB contacts were classified as infected
either if the induration was o5 mm in diameter regardless of
any prior bacille Calmette–Gue´rin (BCG) vaccination [3] or if
clinical, bacteriological or radiological signs or symptoms of
manifest disease were present. If the TST was negative, a second c
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